Abstract:Ubiquitin and the ∼20 human ubiquitin-like proteins regulate numerous aspects of cell biology via interlinked mechanisms that have not been fully elucidated. Sha et al. now explore the interplay between ubiquitylation and SUMOylation, finding that inhibition of ubiquitylation enhances SUMOylation of hundreds of newly synthesized proteins and that the resultant pools are stored in phase-separated protein condensates called PML nuclear bodies. These unexpected outcomes identify a new role for SUMOylation and raise new questions about cell behavior under normal and stress conditions. Ubiquitin and the ∼20 human ubiquitin-like proteins regulate numerous aspects of cell biology via interlinked mechanisms that have not been fully elucidated. Sha et al. now explore the interplay between ubiquitylation and SUMOylation, finding that inhibition of ubiquitylation enhances SUMOylation of hundreds of newly synthesized proteins and that the resultant pools are stored in phase-separated protein condensates called PML nuclear bodies. These unexpected outcomes identify a new role for SUMOylation and raise new questions about cell behavior under normal and stress conditions. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodiesJournal of Biological ChemistryVol. 294Issue 42PreviewProtein ubiquitination and SUMOylation are required for the maintenance of cellular protein homeostasis, and both increase in proteotoxic conditions (e.g. heat shock or proteasome inhibition). However, we found that when ubiquitination was blocked in several human cell lines by inhibiting the ubiquitin-activating enzyme with TAK243, there was an unexpected, large accumulation of proteins modified by SUMO2/3 chains or SUMO1, but not by several other ubiquitin-like proteins. This buildup of SUMOylated proteins was evident within 3–4 h. Full-Text PDF Open Access

Stability of thioester intermediates in ubiquitin-like modifications.

The Intrinsic Affinity Between E2 and the Cys Domain of E1 in Ubiquitin-Like Modifications

Structural basis for transthiolation intermediates in the ubiquitin pathway

E2 Enzyme Inhibition by Stabilization of a Low-Affinity Interface with Ubiquitin.

Mechanism of E1-E2 Interaction for the Inhibition of Ubl Adenylation

Diverse Fate of Ubiquitin Chain Moieties: the Proximal is Degraded with the Target, and the Distal Protects the Proximal from Removal and Recycles.

Interplay Between Ubiquitylation and SUMOylation: Empowered by Phase Separation

Atomic Tailoring of Ubiquitin Side Chains Influences E2‐Mediated Ubiquitin Chain Formation

Lys(6)-Modified Ubiquitin Inhibits Ubiquitin-Dependent Protein Degradation

Specific Substrate Recognition and Thioester Intermediate Determinations in Ubiquitin and Sumo Conjugation Cascades Revealed by A High-Sensitive Fret Assay

Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation

Enhancement of Protein Stability by Quenching Millisecond Conformational Dynamics

Solution Structure of Human SUMO-3 C47S and Its Binding Surface for Ubc9,

Total Chemical Synthesis of Ester-Linked Ubiquitinated Proteins Unravels Their Behavior with Deubiquitinases.

Protein semisynthesis reveals plasticity in HECT E3 ubiquitin ligase mechanisms

Insights into the Allosteric Inhibition of the SUMO E2 Enzyme Ubc9.

Conformational Transition Associated with E1-E2 Interaction in Small Ubiquitin-like Modifications

Biochemical Properties of K11,48-branched Ubiquitin Chains

Identification of a Substrate Recognition Site on Ubc9

Unanchored Ubiquitin Chains, Revisited

Molecular determinants of polyubiquitin linkage selection by an HECT ubiquitin ligase